Glossary

Denied-Party Screening

Also: Restricted-party screening

Checking every party to a transaction against published lists of people and organisations you are prohibited or restricted from dealing with.

For pharmaceutical distribution this spans sanctions lists (OFAC, EU, UN, UK OFSI), export-control lists (BIS), and healthcare-specific lists such as FDA debarment and OIG exclusion.

Effective screening uses fuzzy matching with human adjudication and gates a shipment on a confirmed hit.

See it live in 25 minutes.

Eight guided flows: compliance review, DPS screening, Part 11 e-signature, custody chain, breach prediction, GDPR erasure and the validation report. Then a 90-day pilot on your own programme, fully creditable.